1 / 8

Neurological Biomarker Market Global Trends, Size, Segments and Growth

The neurological biomarker market is expected to reach US$ 14,454.7 million by 2027 from US$ 5,501.8 million in 2019. The market is estimated to grow at a CAGR of 13.0% from 2020 to 2027.<br>

Alex832
Download Presentation

Neurological Biomarker Market Global Trends, Size, Segments and Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Neurological Biomarker Market Trends, Size, Segments, Emerging Technologies 2027 Published Date : May 2022 Email: sales@theinsightpartners.com

  2. Email:sales@theinsightpartners.com Report Studies • Neurological Biomarker Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Others); Application (Alzheimer's Disease, Parkinson's Disease, Schizophrenia, Huntington's Disease, Spinal Muscular Atrophy, Others); End User (Pharmaceutical and Biotechnology Companies, Clinical Diagnostics, Research Organizations); and Geography

  3. Email:sales@theinsightpartners.com Neurological Biomarker Market Overview • The Neurological Biomarker Marketis expected to reach US$ 14,454.7 million by 2027 from US$ 5,501.8 million in 2019. The market is estimated to grow at a CAGR of 13.0% from 2020 to 2027. • The genomic biomarkers segment held the largest share of the global neurological biomarker market, based on product, in 2019, and it is expected to register the highest CAGR during the forecast period. This segment is likely to witness a lucrative growth owing to increasing consumer awarenessabout the benefits of genetic medicines as well as technological advancements in the field of neurological biomarkers. In addition, the growing inclination toward gene counseling and genetic analysis for diagnostic purposes is also likely to propel the growth of the market for genomic biomarkers. The genetic biomarkers are significant modalities that directs towards a more personalized approach of predispositions and medical analysis.

  4. Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Others) • Application (Alzheimer's Disease, Parkinson's Disease, Schizophrenia, Huntington's Disease, Spinal Muscular Atrophy, Others) • End-User (Pharmaceutical and Biotechnology Companies, Clinical Diagnostics, Research Organizations) Download Sample

  5. Email:sales@theinsightpartners.com Neurological Biomarker MarketValue CAGR of 13% (2020 - 2027) Download Sample

  6. Email:sales@theinsightpartners.com Company Profiles • Thermo Fisher Scientific Inc. • Abbott • Myriad Genetics Inc. • Bio-Rad Laboratories Inc. • Qiagen Banyan Biomarkers Inc. • ImmunarrayPvt. Ltd. • Quest Diagnostics Incorporated • PerkinElmer, Inc. • Merck Millipore Download Sample

  7. Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  8. THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related